(https://www.cnbc.com/2026/07/01/kevin-warsh-ecb-forum-live-updates.html) and everyone's assuming lower guidance across the board. But the data splits hard—and the consensus is pricing only one scenario. Defense/space gets crushed on the rate signal. That part's priced. But healthcare and enterprise infrastructure *benefit* from cost discipline and margin engineering.

Research these companies